secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0001178913-25-002900
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeward Q2 revenue $5.7M (-15% YoY); net loss $6.6M; resets 2025 guidance
--------------------------------------------------------------------------

- Revenue $5.7M, down 15% YoY; traditional product revenue $2.5M (-19% YoY) excluding one-time Medicare benefit.
- Net loss $6.6M ($0.58 per share) vs $4.3M ($0.50) in Q2 2024; includes $2.8M goodwill impairment.
- Adjusted net loss $3.5M ($0.31 per share); cash burn improved to $3.9M from $5.6M prior year.
- Record number of ReWalk units placed for Medicare since fee schedule; new CEO Mark Grant and CFO Almog Adar appointed.
- FY 2025 guidance reset to revenue $24-26M and non-GAAP net loss $12-14M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891325002900/0001178913-25-002900-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891325002900/zk2533654.htm
  HTML page:      https://secwatch.observer/filing/0001178913-25-002900

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer